Rising Incidence of Chronic and Infectious Diseases to Drive the India Molecular Diagnostics Market: Ken Research REQUEST FOR SAMPLE REPORT Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit The inclining occurrence of infectious diseases, mounting disposable incomes and growing awareness amongst the consumers will be the key factors driving molecular diagnostics market in India. The prevalence of infectious diseases and epidemics has provided an important impetus to the growth of the India molecular diagnostics market, as these diseases require molecular diagnostic testing. The occurrence of H1N1 (swine flu) has resulted in a speedy augment in clinical laboratories opting for facility upgrades for molecular testing. The common infectious diseases which are most prevalent among the people of India include tuberculosis, HIV, Hepatitis B (HBV), Hepatitis C (HCV) and Human Papillomavirus (HPV). “The molecular diagnostics testing systems enable precise detection of various infectious diseases which include HIV, HBV and HCV. The combination of infectious disease immunoassay and molecular testing offers a complete solution for diagnosis and monitoring of HIV and hepatitis.” – According to the research report ‘India Genomics and Molecular Diagnostics Market Prospects to 2018 – Driven by Automation and Introduction of New Technologies’ by Ken Research. Infectious diseases have remained one of the major concerns for public health in India. Diagnosis of viral diseases is very crucial since it necessitates identification of specific antibodies produced by the immune system. The demand for accurate diagnosis and tests for HBV and HCV has led to the growth of virology segment in the molecular diagnostics market in the country. The emergence of molecular diagnostics in India has helped the physicians to diagnose the diseases and provide effective treatment for the chronic infectious diseases. The growing prevalence of infectious diseases in the country is likely to spur the demand for molecular diagnostics based virology tests in the near future. Growth in the forthcoming years will also be driven by rapid technology developments. With the introduction of latest markers for identifying, selecting and diagnosing specific conditions, market prospects will proliferate. The report provides detailed overview on the molecular diagnostics market in India and help reader to identify the ongoing trends in the key segments of the industry and anticipated growth in future depending upon changing industry dynamics in coming years. The report will aid industry consultants, molecular diagnostics manufacturing companies and marketing companies and other stakeholders to align their market centric strategies according to ongoing and expected trends in future. Post Views: 4